Perceptive Advisors – ALDEYRA THERAPEUTICS INC

Perceptive Advisors ownership history of ALDEYRA THERAPEUTICS INC
QuarterValueSharesWeighting
Q1 2021$206,804
379.6%
17,407,758
177.0%
1.30%
181.9%
Q4 2020$43,118
-7.4%
6,285,4580.0%0.46%
-31.9%
Q3 2020$46,575
262.0%
6,285,458
103.7%
0.68%
226.9%
Q2 2020$12,866
68.8%
3,085,4580.0%0.21%
5.1%
Q1 2020$7,621
-57.5%
3,085,4580.0%0.20%
-44.4%
Q4 2019$17,926
10.2%
3,085,4580.0%0.36%
-18.7%
Q3 2019$16,260
-12.2%
3,085,4580.0%0.44%
3.1%
Q2 2019$18,512
-33.6%
3,085,4580.0%0.42%
-45.9%
Q1 2019$27,862
12.9%
3,085,4580.0%0.79%
-16.3%
Q4 2018$24,684
-42.0%
3,085,4580.0%0.94%
-17.6%
Q3 2018$42,579
73.6%
3,085,4580.0%1.14%
77.1%
Q2 2018$24,529
6.0%
3,085,4580.0%0.64%
-0.8%
Q1 2018$23,141
10.3%
3,085,4580.0%0.65%
-6.8%
Q4 2017$20,981
-52.8%
3,085,458
-50.0%
0.70%
-18.0%
Q3 2017$44,430
231.1%
6,170,916
113.9%
0.85%
25.6%
Q2 2017$13,417
4.0%
2,885,4580.0%0.68%
-8.2%
Q1 2017$12,897
24.2%
2,885,458
48.7%
0.74%
-0.4%
Q4 2016$10,381
-31.6%
1,940,4580.0%0.74%
-24.6%
Q3 2016$15,174
37.4%
1,940,4580.0%0.98%
28.0%
Q2 2016$11,041
112.4%
1,940,458
56.4%
0.76%
67.8%
Q1 2016$5,197
-38.2%
1,240,4580.0%0.46%
-26.7%
Q4 2015$8,410
-24.6%
1,240,458
-35.2%
0.62%
39.5%
Q3 2015$11,160
65.4%
1,914,386
120.1%
0.45%
9.9%
Q2 2015$6,749
85.7%
869,800
143.6%
0.41%
44.0%
Q1 2015$3,634357,0000.28%